Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 664, pseudogene (RN7SL664P)

Target
RN7SL664P
Molecular classification
Other, Pseudogene, 7SL RNA pseudogene, Non-coding RNA
01

Overview

**RN7SL664P** (RNA, 7SL, cytoplasmic 664, pseudogene) is classified as a pseudogene resembling 7SL RNA, a component of the signal recognition particle (SRP) complex which is essential for targeting proteins to the endoplasmic reticulum in eukaryotes[1][3][5][6]. The majority of 7SL-like sequences in the human genome are not functional genes but pseudogenes: non-coding remnants that do not produce functional RNA or protein and arise from reverse transcription of parent 7SL RNA molecules followed by integration into the genome[5][6]. RN7SL664P does not encode a protein, does not have any known biological function, and is not known to play a role in normal physiology or disease[1][5][6]. There are hundreds of such 7SL pseudogenes in the human genome, and while some pseudogenes may acquire regulatory or pathological activity in rare cases, there is currently no evidence for such a role for RN7SL664P in any disease or as a biomarker[1][5][6]. It is not a therapeutic target, and there are no known drug interactions, mechanisms of action, safety concerns, or established biomarker roles for this sequence.\n\n**Summary points:**\n- RN7SL664P is a non-coding pseudogene, not a therapeutic target[1][5][6].\n- It is not associated with disease, drug action, or diagnostic utility.\n- It is an inactive genetic element with no current known biological significance.

Other names
RN7SL664P
02

Mechanism of action

None

03

Biological functions

None (pseudogene, not known to have functional activity)
04

Disease associations

None (no evidence for direct involvement in disease; see context)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 664, pseudogene (RN7SL664P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 664, pseudogene (RN7SL664P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call